Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Adv Mater. 2018 Dec 13;31(6):e1805752. doi: 10.1002/adma.201805752

Quantitative principles for precise engineering of sensitivity in graphene electrochemical sensors

Ting Wu , Abdullah Alharbi , Roozbeh Kiani 2,3, Davood Shahrjerdi 1,4
PMCID: PMC6823930  NIHMSID: NIHMS1004413  PMID: 30548684

Abstract

A major difficulty in implementing carbon-based electrode arrays with high device-packing density is to ensure homogeneous and high sensitivities across the array. Overcoming this obstacle requires quantitative microscopic models that can accurately predict electrode sensitivity from its material structure. Such models are currently lacking. Here, we show that the sensitivity of graphene electrodes to dopamine and serotonin neurochemicals in fast-scan cyclic voltammetry measurements is strongly linked to point defects, whereas it is unaffected by line defects. Using the physics of point defects in graphene, we introduce a microscopic model that explains how point defects determine sensitivity. The predictions of this model match our empirical observation that sensitivity is linearly increasing with the density of point defects. We use this model to guide the nano-engineering of graphene structures for optimum sensitivity. Our approach achieves reproducible fabrication of miniaturized sensors with extraordinarily higher sensitivity than conventional material. These results lay the foundation for new integrated electrochemical sensor arrays based on nano-engineered graphene.

Keywords: graphene, electrochemical sensors, sensitivity, electron transfer, structural defects, FSCV, density of states

Graphical Abstract

Fast scan cyclic voltammetry of dopamine reveals that the sensitivity of multilayer graphene electrodes is linearly proportional to the average density of point defects. This observation is used for precise engineering and prediction of sensitivity in graphene electrodes. A microscopic model based on the physics of point defects in graphene is presented, providing a quantitative framework for explaining this phenomenon.

graphic file with name nihms-1004413-f0006.jpg


The ease of fabrication and operation of carbon-based electrochemical sensors gives them the potential to enable a new class of integrated sensor systems with wide-ranging applications from drug development to clinical diagnostics. To support these applications, the sensor system requires high spatial density (i.e., a dense packing of miniaturized sensors) and consistent operations across the sensor array (i.e., sensors with accurate and homogeneous sensitivity). Moreover, high-precision applications require electrodes with high sensitivity. Although the availability of advanced fabrication techniques would allow miniaturization of carbon-based electrochemical sensors,[14] satisfying the low variability and high accuracy requirements of sensitivity across a dense sensor array remains a difficult challenge.

The sensitivity of this family of sensors is tied to the structural properties of the electrode material.[57] It is natural for the material to have atomic-level structural inhomogeneity, which can cause variability in the electrode sensitivity among sensors. Due to the random spatial distribution of the structural inhomogeneities in the electrode material, this variability becomes more pronounced with reducing the sensor size. To account for the variability and also to determine the electrode sensitivity, the common practice is to calibrate each sensor through post-manufacturing measurements, which involves creating “calibration curves” by measuring the sensor response to known concentrations of analytes.[8] Although this strategy is applicable for dealing with individual devices or a small sensor array, it is highly inefficient for the implementation of large-scale integrated sensor systems. A more tractable approach is to produce carbon-based sensors with precise sensitivity by engineering the material synthesis. However, the efficacy of this approach hinges on a quantitative understanding of the precise relationship between the structural properties of the material at the nanoscale and the sensitivity of the electrode at a macroscale.

Pioneering studies, including those by McCreery et al.,[912] have suggested that the electron transfer in sp2-based carbon electrodes (e.g., carbon nanotube and graphene-related materials) is enhanced at the edge plane sites. Others have inferred that oxygen-containing functional groups in these materials can also promote electron transfer.[13,14] Since electron transfer is a fundamental process that determines sensitivity, step edges and oxygen-containing functional groups are commonly assumed to be responsible for the experimental observations of enhanced sensitivity in sensors made from sp2 carbon materials.[1518] In recent years, however, researchers have pointed to additional active electrochemical sites in sp2 carbon materials by using scanning electrochemical cell microscopy (SECCM). For example, seminal studies by Unwin et al.,[1923] and others[24, 25] have shown that the basal planes of sp2 carbon materials are electrochemically active. Moreover, it has been suggested that point defects are active electrochemical sites in monolayer graphene.[26] Further, using an improved SECCM, Güell et al. have shown the enhanced electrochemical activity of step edges in graphene.[27] While the literature on electron transfer is still evolving,[2830] these past studies have advanced our knowledge about the correlation between nanoscale structural properties and electron transfer in sp2-based carbon electrodes.

However, there still remain significant gaps in our knowledge pertaining to how different structural properties of sp2 carbon materials quantitatively determine the sensitivity of an electrode. These knowledge gaps exist because an electrode material, which is a macroscopic system, often simultaneously contains a variety of nanoscale features (defects or functional groups) in its structure, which past research has identified as active electrochemical sites. Consequently, two questions critical to precise engineering of a sensor remain unanswered: Which of those nanoscale features in the material structure affect the electrode sensitivity the most? And, more importantly, how must one tune their quantity to precisely achieve a desired sensitivity? Given that the electronic band structure is altered by introducing defects or functional groups in a material structure, the answer to the latter question requires accurate microscopic models that can quantitatively predict sensitivity from the changes in the electronic band structure. Such predictive models are severely lacking, yet are critical for developing a sensor device technology, where one can reliably produce miniaturized sensors with the desired characteristics of high and homogeneous sensitivities across an array.

Our study here focuses on providing a predictive model for graphene sensors. The model depicts, on a microscopic level, how the sensitivity of graphene and its electronic band structure are affected by structural defects in graphene. We achieve this model by systematically studying the sensitivity of miniaturized electrochemical sensors made of disordered multilayer graphene to neurochemicals (dopamine and serotonin) using fast-scan cyclic voltammetry (FSCV) technique. Graphene is an excellent test vehicle for this study since, as we show below, it is easy to produce defect-engineered graphene films with precise amounts of defects and quantify the defects using experimentally-established Raman-based models.[3135] Specifically, we used multilayer graphene to suppress any interference from charged impurities at the interface of the graphene sensors and the oxide substrate. In fact, a recent SECCM study has shown significant variations of electron transfer across the surface of a monolayer graphene on a SiO2 substrate.[27] In contrast, they have also shown that the presence of multiple layers can effectively shield the electrode surface (where the electron transfer occurs) from charge impurities in the substrate. Our tight control over the sensor fabrication process, together with the accuracy and reproducibility of our material characterizations and sensor measurements, have allowed us, for the first time, to experimentally determine the accurate relationship between the average density of point defects and the FSCV sensitivity of multilayer graphene electrochemical sensors to neurochemical molecules. Importantly, uncovering this relationship allows us to propose a microscopic model that can quantitatively explain the sensitivity of multilayer graphene sensors based on the density of electronic states in the material.

We use the predictions of our microscopic model for nano-engineering the structural properties of multilayer graphene electrodes on an atomic level to precisely match a desired sensitivity. We show that our engineered electrodes exhibit up to 20 times higher sensitivity to dopamine than conventional carbon fiber (CF) electrodes in FSCV measurements.[3638] Moreover, we demonstrate that our model consistently applies to multilayer graphene sensors produced through different synthesis methods, promising wide applicability of our paradigm for prediction and engineering of the sensitivity of carbon-based electrochemical sensors.

Results

Enhanced electrode sensitivity in multilayer graphene:

To evaluate the link between the atomic structure of multilayer graphene and the sensitivity of electrodes made of it, we performed electrochemical sensing of biochemical molecules using FSCV. Owing to its good ionic specificity and sub-second detection ability, FSCV with carbon-based electrodes has been used extensively for measuring biochemical molecules in chemically complex environments such as the brain.[15,36,39,40] We initially constructed FSCV electrodes using multilayer graphene grown by chemical vapor deposition (CVD) and measured their sensitivity to neurochemical molecules in vitro. CVD graphene films typically have different amounts of sp2-hybridized defects, due to minor differences in the production method, apparatus, or even the granular structure of the growth substrate.[41,42] To increase the diversity of different defect densities in our sensor electrodes, we obtained several batches of CVD multilayer graphene films grown on nickel foils.

To fabricate electrodes, we transferred the CVD multilayer graphene films with an average thickness of 35 nm onto SiO2/Si substrates using standard chemical layer-transfer processes.[4345] Using nanofabrication, we then made miniaturized sensor electrodes with a planar geometry, shown schematically in Figure 1a. The details of the fabrication process are given in Supporting Information (section S1). We used a similar process for fabricating all devices discussed in this paper. We designed the fabrication process around two key factors. The first one is to avoid creating unintentional defects in multilayer graphene during the sensor fabrication (see Figure S3). This consideration is particularly important when making electrodes from defect-engineered multilayer graphene, discussed later. To do so, during the fabrication process, we protected the sensing region of the electrode with a thin metal layer (Cr/Au; 5 nm/50 nm). Second, for analyzing the sensor response in our study, we used the areanormalized sensitivity. We defined the sensing region of the electrodes accurately using an SU8 encapsulating layer. This layer also protected the metal contact from exposure to the electrolyte solution. To perform the sensing experiments, we removed the protective metal stack and mounted a fluidic chamber on the samples. Figure 1b shows the top-view scanning electron microscopy (SEM) image of an example sensor array. For comparison, we also fabricated electrodes from conventional CFs (Figure S4), commonly used in FSCV measurements of neurochemicals in the brain.[37,46]

Figure 1.

Figure 1.

FSCV sensors made of multilayer graphene films with different amounts of structural defects. (a) Schematics of a multilayer graphene electrode used for FSCV measurements. The multilayer graphene electrode was mounted on a SiO2/Si substrate and connected to a Cr/Au contact. A fluidic chamber filled with PBS solution of target biochemicals (dopamine or serotonin neuromodulators) was made around the sensor. To maintain neuromodulator concentration at a desired level, fresh solution was brought to the chamber by an inlet and old solution was taken out by an outlet. (b) The SEM image shows an example of our miniaturized multilayer graphene sensor array and fluidic chamber around the sensors. We used nanofabrication to build miniaturized sensors from our candidate multilayer graphene films. Scale bar is 300 μm. (c) Topographic image of an example CVD multilayer graphene sensor and its thickness measured by atomic force microscopy. Scale bar is 5 μm. (d) In FSCV measurements of dopamine, the voltage is applied to the sensor electrode; it first quickly ramps up, which oxidizes dopamine to dopamine-o-quinone, and then ramps down, which reduces it back to dopamine. The resulting current is measured. (e) Area-normalized electrochemical current (iEC) as a function of time in one FSCV cycle for four sample electrodes made of CVD multilayer graphene films and carbon fibers. We also show the voltage waveform applied to the electrode. In all FSCV measurements, we used a voltage scan rate of 400 V/s and a repetition frequency of 10 Hz. P1 and P2 denote the oxidation and reduction peak potentials. The noticeable variations of iEC for these sensors in response to the same dopamine concentration highlight the critical role of structural defects on sensitivity.

We characterized the sensitivity of the fabricated sensors through FSCV measurements of dopamine—an important neuromodulator for action-selection and reward-motivated behavior.[4749] During the FSCV measurement (see section S3 for details), dopamine (the reductant, R) undergoes a redox reaction (Figure 1d), where it is oxidized to dopamine-o-quinone (DOQ) (the oxidant, O) by a voltage ramp-up applied to the electrode (see Figure 1a). The amplitude of the resulting oxidation current is a measure of the dopamine concentration. The voltage subsequently ramps down, causing the DOQ molecules to be reduced back to dopamine, which gives rise to a reduction current. FSCV estimates dopamine concentration based on the magnitude of the oxidation current. Electrode sensitivity represents the change in the peak of the oxidation current (ip,ox) per unit concentration of a biomolecule (Figure S6c,d). We defined unit concentration as μM and the area-normalized sensitivity, SA, as ip,ox at 1 μM divided by electrode area. Because the amplitude of the electrochemical current is proportional to the geometric surface area of the sensors, normalization of sensitivity by sensor area enables comparison of sensors with diverse sizes. Surface roughness increases the geometric surface area and can potentially bias the area-normalized sensitivity. Therefore, we estimated the total surface area of our multilayer graphene sensors by performing atomic force microscopy (AFM) and measuring surface roughness before the FSCV experiments (Figure 1c, Figure S7, S8). As a result, our area-normalized sensitivity is independent of the sensor geometry and reflects the inherent sensing property of the electrode material.

Figure 1e shows the area-normalized electrochemical current (iEC) curves for four example electrodes (three CVD and one CF) in response to a 1 μM dopamine solution. The orange circles on the curves denote ip,ox. This plot and the FSCV measurements of the other CVD electrodes (Figure S9) demonstrate the substantial variations in electrode sensitivity. Many sensors were minimally responsive to dopamine molecules and a few showed noticeably higher SA than the CF devices. We hypothesized that the diversity of structural defects of the sensing material was crucial for explaining the wide range of observed electrode sensitivities.

Quantifying structural defects in carbon-based electrodes:

The ability to distinguish different types of defects and quantify their amounts in the electrode material is critical for revealing the connection between structural defects and the electrode sensitivity. While the types of structural defects are diverse, one simple way to classify them is based on their dimensionality. For example, defects in materials with a two-dimensional lattice, such as graphene, are either zero-dimensional (point defects) or one-dimensional (line defects). Examples of point defects in graphene are vacancies,[5052] topological defects such as Stone-Wales defect,[51,52] and dopants.[53] On the other hand, crystallite edges[32] and extended dislocations[51] are examples of line defects. Point and line defects are often simultaneously present in synthetic graphenebased materials, as shown schematically in Figure 2a. Physics-based models that use Raman spectroscopy data have been experimentally established for identifying and quantifying sp2-hybridized defects in graphene based on their dimensionality.[3135] Specifically, scanning tunneling microscopy (STM) measurements, which are the gold standard for determining the structure and distribution of defects on an atomic scale, are used to calibrate and validate these Raman-based quantitative models.

Figure 2.

Figure 2.

Quantifying structural defects in graphene electrodes. (a) Line and point defects are typically present at the same time in synthetic multilayer graphene films and can be characterized by the average crystallite size, La, and average distance between point defects, LD, respectively. (b) To evaluate the structural properties of the CVD films, we used Raman spectroscopy. The increase of the D peak intensity for samples from bottom to top indicates the higher density of sp2-hybridized defects. The gradual changes of the Raman peaks also highlight the transition from a graphitic structure in stage (i) into a fully disordered sp2 carbon in stage (ii). Conventional CFs are typically in stage (ii) as shown by the example electrode in the top row. Area-normalized sensitivity, SA, is indicated for each sample electrode. (c) Spatially resolved La and LD across the sensor surface for an example CVD electrode. To estimate the average density of point and line defects, we obtained similar spatial maps for all electrodes studied in this work. (d) The scatter plot of the average crystallite area (L¯a2) and the average point defect density (L¯D2) shows that our candidate materials covered a broad range of defect densities. Numbers next to the CVD samples indicate example electrodes in panel b. The yellow shading represents the stage (ii) of the amorphization trajectory, while the gray box marks the detection limit of Raman for estimating the point and line defect density.

Figure 2b shows representative Raman spectra for a few CVD samples and a CF electrode. The distinct peaks in the Raman spectrum of multilayer graphene films are wellstudied.[54,55] The G peak appears at about 1579 cm−1 and signifies the sp2-hybridization of carbon atoms. The D peak arises from the breathing modes of aromatic carbon rings and signifies sp2-hybridized defects. The 2D peak is the second-order of the D peak, which is present only in fully sp2-bonded carbon materials. Changes of these peaks in Figure 2b (from bottom to top) illustrates the gradual transition of the film structure (i) from a highly ordered multilayer graphene to a disordered nanocrystalline graphite and (ii) finally to a fully disordered sp2 carbon material. In stage (i), the D peak intensity increases monotonically and the 2D peak is visible in the Raman spectra. Upon transition into stage (ii), the 2D peak becomes noticeably broad and its intensity weakens dramatically. The combination of our CVD and CF electrodes covered the whole spectrum of the graphene amorphization trajectory.

We applied a theoretical method by Cançado et al.[35] for extracting the amounts of point and line defects from the measured Raman spectra of our sensor samples. This method has also been validated using previously published STM data, illustrating its ability to unambiguously distinguish point and line defects in graphene-based samples.[35] Although, unlike STM, the Raman-based methods lack single defect resolution, they are suitable for accurate quantification of average defect densities in graphene films when the defect density is moderately high (i.e., > 1011 cm−2). This theoretical method relies on numerical simulations based on the area ratio of the D and G peaks and the line width of the G-band to derive the average crystallite size (La) and the average distance between point defects (LD) within the spot size of the Raman laser. The details of our La and LD calculations are given in section S4 of the Supporting Information. We note that this methodology for quantifying defects is independent of the production method of multilayer graphene, making it suitable for our study involving CVD, graphitized, and CF materials.

Since the location of defects on a sensor electrode is random, we estimated the density of each defect type on a sensor electrode by measuring the number of defects averaged over the sensor surface area. To do so, we first obtained the spatial Raman maps of our sensor electrodes and quantified La and LD at each Raman spot. Figure 2c shows the spatially resolved distributions of La and LD for an example CVD electrode (Figures S14 to S18 show the spatial distribution of defects for all electrodes used in this study). The mean values from the La and LD distributions were then used for estimating the average density of point defects (n0D=L¯D2) and average crystallite area L¯a2 in our sensor samples. This methodology allows us to analyze the relationship between the area-normalized sensitivity and the density of each defect type in our carbon-based electrodes.

Figure 2d shows the scatter of L¯D2andL¯a2 for our CVD sensor samples, highlighting the large diversity of line and point defects in our candidate sensor samples. In this plot, the gray box (in the lower right corner) marks the region, where Raman lacks accuracy for estimating point and line defect densities, because the expected LD and La values are beyond the upper detection limits of Raman. The Raman spectra of samples that fall in this region typically do not show a visible D peak. We refer to those samples, with no detectable defect density by Raman, as pristine. Moreover, past Raman studies of defective graphene suggest that the onset of stage (ii) of the amorphization trajectory occurs at LD of about 4–5 nm.[34] Notably, this length scale is comparable to the localization length of the disorder-induced Raman D band at 300 K.[56] The yellow shading in Figure 2d marks the stage (ii), which includes the CF sample. In contrast, our CVD sensor samples were in stage (i) of the amorphization trajectory.

Revealing the effect of defects on electrode sensitivity:

To reveal the quantitative effect of defects on the sensitivity of multilayer graphene sensors in stage (i) of the amorphization trajectory, we made a contour plot of the area-normalized sensitivity (SA) as a function of the average crystallite area and (L¯a2) the average point defect density (L¯D2), shown in Figure 3a. The plot shows that electrodes with similar density of point defects exhibited nearly similar SA, regardless of their L¯a2. Further, SA was amplified with increasing the density of point defects. The apparent increase of SA with point defect density is reminiscent of a previous study reporting that point defects enhance electron transfer in irradiated monolayer graphene.[26]

Figure 3.

Figure 3.

Revealing the link between structural defects and electrode sensitivity. (a) Contour plot of SA versus L¯a2andL¯D2, indicating that the sensitivity of the CVD sensors in stage (i) was largely independent of the average density of line defects and was amplified by increasing the average density of point defects. (b) We found that SA of the CVD sensors in stage (i) was amplified in linear proportion to the density of point defects, and dropped upon transition into stage (ii) (yellow shading). The magenta dashed line represents the measurable limit of SA in our sensor readout system. The error bars of SA were too small (below 3%) to show in the plot. The sensitivity of electrodes from pristine graphene was below the measurable limit. The numbers next to the data correspond to the sensors in Figure 2b.

Next, we analyzed the relationship between SA and the average point defect density (i.e., n0D=L¯D2). Interestingly, we observed a linear relation between the area-normalized sensitivity and the point defect density when the sensing material was in stage (i), as shown in Figure 3b. The linear fit to the data in this plot is given by

SA=(6.46±0.16)×1011(n0Dn0D*) (1)

where n0D* is the x-intercept of the linear fit and has a value of (1.6 ± 0.24) × 1011 cm-2. Further, SA and n0D have units of pA μm−2 μM−1 and cm−2, respectively. In this equation, in addition to the coefficient estimates (slope and intercept), we also provide their standard errors. We note that in our experiments, the sensitivity of electrodes containing a point defect density below n0D*, including those made of pristine graphene, was below the measurable limit of our readout system (the magenta dashed line in Figure 3b). From the data, we also found that upon transition into stage (ii), which includes the CF electrode, SA no longer follows the linear trend. These results clearly illustrate the critical role of point defects on the sensitivity of graphene electrodes.

Uncovering the tight linear relationship between SA and the point defect density in our preliminary sensing experiments has two important consequences. The first one relates to the development of a sensor device technology. If this tight relationship is valid for the entire range of defects in stage (i), it suggests an opportunity for precise engineering of the sensitivity by controlling only the amounts of point defects using the empirical Equation (1). The second significance of our observation is fundamental to understanding the electron transfer in graphene. Specifically, the observed linear trend allowed us to propose and subsequently test a simplified microscopic model (discussed next) that can quantitatively and accurately explain the relationship between sensitivity and point defect density in graphene electrodes.

Proposed microscopic model of sensitivity in graphene:

The linear relationship between SA and n0D in Figure 3b provides strong evidence that each point defect in stage (i) of the amorphization trajectory acts as an independent active electrochemical site. On the basis of this evidence, we propose a microscopic model to quantitatively explain the apparent linear relationship between the sensitivity and the density of point defects in graphene sensors. Our model builds on the assumption that the point defects in our multilayer graphene films are predominantly vacancies and the equilibrium concentration of topological point defects (e.g., Stone-Wales defects) is negligible.[52,57] Given the high formation energy of Stone-Wales defects (the simplest form of a topological point defect) in graphene,[58] this is a reasonable assumption. Based on this assumption, we developed our microscopic model by utilizing three established phenomena related to the physics of the vacancy defects in graphene, discussed below.

The first phenomenon relates to the increase in the density of states (DOS) of multilayer graphene with the spatial density of point defects. Past theoretical studies predict that vacancy-type disorders in the graphene lattice with a sub-nm length scale behave similarly, in that they each locally alter the electronic band structure of graphene at the defect site by creating almost the same amounts of excess DOS at an energy corresponding to the Dirac point, ED.[59] Figure 4a schematically illustrates this phenomenon. These theoretical expectations are supported by past STM studies[60,61] that demonstrated an increase of the local density of states (LDOS) at point defect sites. Moreover, those studies have shown that the electronic perturbations induced by the vacancy defects have a length scale of about 5 nm diameter[60,61] At this length scale, uniformly spaced point defects formed during stage (i) of the graphene amorphization trajectory (i.e., LD ≥ 5 nm) are spatially non-overlapping (Figure 4b). Hence, we expect that DOS at ED in this regime will increase in linear proportion to the spatial density of point defects, n0D. Specifically, the electronic DOS of graphene (per unit area) at the Dirac point in stage (i) of the amorphization trajectory can be estimated from the following expression

DOS(ED)=yxLDOS(x,y,ED)A0D×n0D×LDOS(x0,y0,ED) (2)

where A0D and LDOS(x0, y0, ED), respectively, represent the average area of the electronic perturbation due to a single point defect (i.e., the area of the yellow circles in Figure 4b) and the local density of states at a point defect site at an energy of ED. In the approximation on the right hand side of the equation, we ignored the LDOS of the defect-free graphene regions at ED. This is a reasonable assumption given the significantly smaller LDOS of those regions at ED compared with the defect sites, as shown in Figure 4a.[59,61] The linear increase of DOS(ED) with n0D is expected to persist in stage (i) until the electronic states induced by the point defects begin to overlap (see Figure 4c), corresponding to the onset of the transition to stage (ii) of the amorphization trajectory.

Figure 4.

Figure 4.

Proposed microscopic model of the electrode sensitivity. (a) Schematic illustration of LDOS at a vacancy point defect site (x0, y0) and a defect-free region of graphene (x1, y1). These point defects induce localized electronic states at the Dirac point, ED. (b), (c) Schematic illustrations of LDOS distribution at ED across a graphene surface in stage (i) and the onset of stage (ii) of the amorphization trajectory, respectively. The green circles represent the structural disorder in graphene lattice with a sub-nm length scale. The yellow circles denote the excess electronic states induced by the point defects with a length scale of 5 nm diameter. (d), (e) Proposed local energy band diagram at each point defect site, corresponding to the oxidation peak potential P1 and the reduction peak potential P2, respectively. These potentials are marked in Figure 1e. In sensing measurements, the FSCV voltage is applied to the graphene electrode and measured with respect to the potential of the solution. The solution potential is constant and serves as the voltage reference. EF0DandEFS denote the quasi-Fermi levels in the graphene and in the solution. Note that the EF0D follows the voltage due to the Fermi level pinning by the point defects. DR and DO are the DOS of the reductant (e.g., DA) and the oxidant (e.g., DOQ). The arrows in those plots indicate the direction of electron tunneling. Gray shading denotes filled energy states on both sides of the interface between the graphene and the molecule (magenta dashed line). (f) Our model captures the underlying mechanisms of the FSCV sensitivity from nanoscale to macroscale. Localization of the defect-induced states in the out-of-plane direction at each point defect site facilitates the electron transfer (step 1). n denotes the number of electrons involved in this example redox reaction. Due to the delocalization of the defect-induced electronic states in the in-plane direction, the transferred electrons between the molecule and the defect become mobile charge carriers in graphene and are transported to the metal contact (step 2). The collective contribution of nanoscale defects produces a macroscopic redox current iEC.

The second phenomenon relates to the fact that the electronic state induced by a vacancy point defect in graphene, shown in Figure 4a, is pinned to the Fermi energy at the Dirac point ED.[6165] Specifically, the pinning of the Fermi level occurs only in the regions of graphene, where the electronic band structure is modified by the vacancy defect (the yellow circles in Figure 4b). We denote the Fermi level in those regions of graphene as EF0D. In contrast, the Fermi level at the defect-free regions of graphene remains unpinned. An important consequence of the Fermi level pinning at the vacancy defect states is that those electronic states move with when a voltage bias is applied to graphene. As a result, during the sensing experiments, those defect-induced electronic states follow the FSCV voltage waveform applied to the graphene electrode. In Figure 4d and 4e, we schematically show the local energy band diagrams of the graphene-molecule system at a point defect site in a direction perpendicular to the graphene surface (i.e., out-of-plane direction). These two band diagrams, respectively, correspond to the FSCV voltages at which the peak oxidation or peak reduction occur. Specifically, when the defect-induced states align with the DOS of a molecule (either the reductant states DR or oxidant states DO), the electron transfer between the molecule and the point defect occurs. In these band diagrams, note the directions of the electron transfer (via tunneling) between the molecule and the point defect in graphene.

Finally, the Fermi-energy states induced by the vacancy point defect sites in graphene are localized in the out-of-plane direction and delocalized in the in-plane direction.[65] Localization in the out-of-plane direction facilitates electron transfer between the molecule and the point defects. On the other hand, delocalization in the in-plane direction allows lateral transport of the transferred electrons between each point defect site and the metal contact through the defect-free regions of graphene, as shown in Figure 4f. In particular, this property of the vacancy point defects allows the transferred electrons at different point defect sites to become mobile charge carriers in graphene, hence collectively produce a measurable redox current (iEC).

The Gerischer-Marcus framework[66,67] can be used to show that the electron transfer rate is approximately proportional to the DOS of the electrode material at about the Fermi energy.[68, 69] This approximation together with the above-mentioned phenomena simplify the quantification of the electron transfer rate. Specifically, because EF0D. of graphene is pinned locally at each point defect site to ED, and because DOS(ED) in the graphene electrode is linearly proportional to n0D, the electron transfer rate and hence the area-normalized sensitivity of graphene scale in linear proportion with the average density of point defects in stage (i) of the amorphization trajectory. This proposed microscopic model supports our empirical equation for SA obtained from the data in Figure 3b.

Our theoretical model, supported by the physics of vacancies in graphene, provides a powerful, quantitative framework for explaining the sensing mechanism in multilayer graphene electrodes based on the density of electronic states. Also, note that our proposed model of electron transfer for point defects is independent of the redox potential of the target molecule, and hence it can be applied to a variety of molecules as long as their redox potentials lie within the voltage range of FSCV.

On the basis of our observations in Figure 3 and the proposed microscopic model, we made the following hypotheses for engineering the FSCV sensitivity of electrochemical sensors made of multilayer graphene containing a variety of defect types. First, the synthesis process does not need to be optimized for line defects, because, as shown in Figure 3a, they had no observable effect on the electrode sensitivity of the CVD sensor samples. Second, the defect-free portion of the basal plane of graphene has no measurable contribution to the sensitivity. Third, the density of point defects alone is sufficient for accurately predicting the FSCV sensitivity of the electrode through the apparent linear relationship in stage (i), described by Equation (1). Fourth, the sensitivity degrades as the material structure transitions into stage (ii). Based on these hypotheses and the prediction of our microscopic model, we expect that the highest SA can be obtained by maximizing the density of point defects in multilayer graphene before transitioning to stage (ii) of the amorphization trajectory. We tested these hypotheses using electrodes made of defect-engineered multilayer graphene, discussed next.

Engineered electrodes with predictable sensitivity:

We directly tested the validity of our hypotheses in sensing experiments with electrodes fabricated from multilayer graphene with different amounts of point and line defects. Based on our microscopic model, we expect that these hypotheses can be generalized to different graphene production methods. Therefore, while Figure 3 was obtained from sensors produced using CVD, we tested the hypotheses on sensors produced by a different graphene production method. Further, we conducted the sensing experiments on two biologically active compounds, dopamine and serotonin.

We first developed a synthesis process that allowed us to engineer multilayer graphene films with different amounts of point and line defects. Of the various approaches for producing multilayer graphene,[41,44,7072] we adapted a method based on metal-induced transformation of amorphous carbon to multilayer graphene using a thin nickel catalyst.[73,74] Our process involved creating amorphous carbon islands directly on SiO2/Si substrates and graphitizing them at temperatures between 1000 and 1100 ºC, as shown in Figure 5a (see section S5 in Supporting Information for details of the graphitization process). We probed the graphitic structure of the samples using high-resolution x-ray photoelectron spectroscopy (XPS) (Figure 5b). Curve fitting of the XPS data indicated the sp2 nature of the carbon-carbon bonds. The 2D peaks in Raman spectra of the films (Figure 5c) further confirmed the multilayer graphene growth. We observed that the structural properties of the multilayer graphene films made from this method is sensitive to the nickel thickness, annealing temperature, and growth time. By tuning these parameters, guided by Raman analysis, we could reliably and reproducibly generate samples with desired amounts of structural defects. We refer to these multilayer graphene samples as the graphitized (GR) samples.

Figure 5.

Figure 5.

Engineered multilayer graphene sensors with predictable sensitivity. (a) To test the validity of our hypotheses, supported by our microscopic model, we produced engineered multilayer graphene through nickel-induced graphitization of amorphous carbon (a-C). (b) XPS measurements confirmed the graphitic nature of the films through the presence of sp2-hybridized C-C bond peak highlighted in red. (c) We used Raman measurements to quantify the structural defects in our GR samples. (d) We created three groups of GR samples. A first group that had overlapping density of point defects with the CVD sensors; a second group which contained a higher density of point defects than the CVD samples without transitioning to stage (ii); and a third group that had even higher density of point defects and were in stage (ii) (yellow shading). Numbers next to the data points denote the example GR (I, II, III, IV) and CVD (1, 2, 3) electrodes in panel c and Figure 1b, respectively. The error bars were too small to show in the plot. (e) From the FSCV measurements of dopamine, we confirmed that the electrode sensitivity of the GR samples was largely independent of the crystallite size and increased with the point defect densities. (f) We found that GR sensor samples with a similar density of point defects to CVD samples had the same SA. By increasing the density of point defects in stage (i), we achieved a maximum SA of about 177 pA μm−2 μM−1, which is about 20 times higher than conventional CFs. The electrode sensitivity decreased rapidly once the structure of the carbon lattice transitioned into stage (ii). The magenta dashed line denotes the minimum measurable limit of SA in our experiments. The error bars of SA were too small to show in the plot.

In our experiments, we created three sets of GR sensor samples. The first group of sensor samples contained the same amounts of point defects as the CVD samples. This was to reproduce the sensitivity of those CVD electrodes and hence to demonstrate that our empirical equation of the electrode sensitivity is independent of the graphene production method. The second group of samples had significantly higher amounts of point defects than the CVD devices without transitioning to stage (ii). This set of GR samples allowed us to investigate the ability of our empirical equation for predicting SA in the range of point defect densities that was not covered by the CVD sensor samples, hence testing the validity of our microscopic model. Further, using these samples we were able to explore the upper limit of SA in stage (i). We also created a third group of GR samples, which were in stage (ii) of the amorphization trajectory of graphene. These samples allowed us to confirm the drop in SA upon transition into stage (ii). Figure 5c shows the representative Raman spectra of a few GR samples and their corresponding SA for dopamine. In Figure 5d, we show the summary of average point and line defect densities for our engineered GR samples. In this plot, we have also included the CVD and CF samples to facilitate the distinction between the three groups of the GR samples. In addition to regions of overlap with the CVD and CF samples, note the region where the GR samples were engineered to have a significantly higher point defect density than the CVD samples without transitioning to stage (ii), the yellow shading in the plot.

We used miniaturized electrodes fabricated from defect-engineered GR films to perform FSCV measurements of dopamine (Figure S10). Figure 5e shows the contour plot of SA for the GR and CVD electrodes, where the multilayer graphene sensor electrodes are in stage (i). The plot shows that, like the CVD samples, the FSCV sensitivity of GR electrodes increased with the point defect density and was independent of the crystallite size. Plotting SA as a function of the point defect density (see Figure 5f) revealed three critical results, confirming our hypotheses. First, the SA of the GR sensors closely followed the same linear trend as the CVD samples, confirming that the average density of point defects was the main predictor of the SA for multilayer graphene films in stage (i). Specifically, the data points are well within the confidence bands of the linear regression (see Figure S20), suggesting the statistical reproducibility of the electrode sensitivity for a particular defect density. Figure S22, S23, and S24 in Supporting Information (section S6) provide additional support for the reproducibility of the sensor manufacturing process. The exact method of production of the multilayer graphene film did not matter as long as the point defect density remained the same, hence confirming that our empirical equation of SA can be generalized to other graphene production methods. Moreover, these results establish the validity of our microscopic model for quantitatively describing the FSCV sensitivity of graphene electrodes. Second, by increasing the density of point defects in stage (i), our model predicts that one could maximize SA. Indeed, we achieved a remarkably high SA of 177 pA μm−2 μM−1 in response to dopamine, which is up to 20 times higher than the area-normalized FSCV sensitivities reported for CF electrodes in past studies.[75,76] Third, our data indicate that SA began to degrade at a point defect density corresponding to a LD of about 5–6 nm, which coincides with the onset of graphene transition to stage (ii). Most strikingly, this length scale agrees with our proposed microscopic model in Figure 4, where the electronic perturbations at the point defects begin to overlap (Figure 4c). Conventional CF electrodes that are used for studying neurochemical changes in the brain.[36,38,75,77] are usually in this regime. Our finding explains the fundamentally small sensitivity of these electrodes and suggests a practical method to significantly boost the electrode sensitivity for such measurements.

To ensure our results were not limited to a particular molecule, we also performed in vitro FSCV measurement of serotonin neurotransmitters using the multilayer graphene electrodes in stage (i). The results confirmed that the linear increase of electrode sensitivity with increasing average point defect density generalized to serotonin and was, therefore, a property of the electrode and not the measured analyte (Figure S25, S26).

To examine the role of oxygen functional groups in FSCV sensitivity of graphene electrodes to dopamine and serotonin, we performed XPS measurements on multiple multilayer graphene sensor electrodes with markedly different SA. The electrodes were chosen from both CVD and GR sensor samples and the XPS measurements were performed immediately after the FSCV experiments in an ultra-high vacuum (UHV) environment. By analyzing the XPS data (Figure S27), we observed a noticeable variation in the amount of oxygen-containing groups among the sensors. This observation together with our finding that 99% of the variation in sensitivity is explained by the average density of point defects (R2 of the linear regression in Figure 5f) suggest that the amount of oxygen functional groups is not a dominant factor in defining the sensitivity of multilayer graphene electrodes in FSCV measurements of dopamine and serotonin.

Conclusions

Our findings establish the fundamental principles for predicting the FSCV sensitivity of multilayer graphene electrochemical sensors to neurochemical molecules based on structural defects. Using these principles, we devised an approach for nano-engineering graphene, resulting in the reproducible and reliable fabrication of homogeneous sensors with optimized sensitivity. We found that in a graphene sensor consisting of a variety of defects, the density of point defects can be used as the main predictor of the sensitivity. This is evident from the excellent agreement between the predictions of our empirical equation of the electrode sensitivity and the measured data (see Figure S21). Moreover, the remarkably high sensitivity of our miniaturized electrodes is due to the maximization of point defect density while keeping the electrode material in stage (i) of the amorphization trajectory of graphene.

The density of line defects and oxygen-containing functional groups appear to have minimal bearing on the FSCV sensitivity of multilayer graphene electrodes to dopamine and serotonin. This observation simplifies the electrode manufacturing process by removing the need for monitoring and optimization of line defects and oxygen-containing groups. However, these functional groups may still be electrochemically active. Additional studies are required to explore the exact role of oxygen-containing groups and their interactions with point defects. An exciting possibility is to further increase the sensitivity of our nano-engineered electrodes by adding functional groups that amplify the effect of point defects.

The increase of electron transfer in graphene and other related materials due to the emergence of excess DOS in the electronic band structure is well-known.[26,27,7880] However, less understood is how to reliably quantify the macroscopic electrode sensitivity in FSCV measurements using DOS of graphene. Our proposed model, supported by the physics of point defects, is the first to provide a theoretical framework that can allow the calculation of SA in a graphene sensor containing point defects. Specifically, our model offers a quantitative and accurate understanding of the underlying mechanisms that shape the FSCV sensitivity of graphene electrodes, from the electron transfer at the defect sites to the collection of those charge carriers by the metal contact made to the graphene electrode.

Uncovering the linear relationship between SA and the density of point defects through FSCV of neurochemical molecules was critical for developing the microscopic model of the electrode sensitivity. We were able to uncover this linear relationship because of the accuracy and reproducibility of our material characterization, device fabrication process, and sensing measurements. In particular, we attribute the reliability of our sensing measurements primarily to our use of multilayer graphene as the electrode material, hence mitigating the interference from the charge impurities at the graphene-SiO2 interface. This is consistent with the findings of a previous SECCM study, demonstrating that whereas multilayer graphene is immune to substrate effects, using SiO2 substrate causes noticeable fluctuations in electron transfer of monolayer graphene.[27]

The underlying mechanisms of electron transfer in our model are independent of the number of layers in graphene. Therefore, though we used multilayer graphene in these experiments, we expect our findings to hold for sensors made of graphene with different number of layers, i.e., monolayer, bilayer, or more. In the case of monolayer graphene, however, given that its inherent electron transfer is very susceptible to stray charges in the substrate,[27] care must be taken when using monolayer graphene sensors for conducting similar experiments.

Note that in our experiments, we have examined the FSCV response of the graphene sensors for dopamine and serotonin molecules. An exciting future direction is to investigate whether the findings of our paper extend to other redox reactions including those of outer sphere systems. Those future studies include testing the validity of the linear relationship between the FSCV sensitivity and the average density of point defects in stage (i) for other redox systems, and hence confirming the generalizability of the microscopic model.

In this study, we used Raman spectroscopy to classify the structural disorders in our multilayer graphene films based on their dimensionality. We next defined the sub-types of these defects in our multilayer graphene films. In the case of point defects, Raman is unable to distinguish between topological (e.g., Stone-Wales) and vacancy point defects, since both of these sub-types of point defects are symmetry-breaking and hence influence the Raman D-band. However, for two reasons, we can infer that the type of point defects present in our material are predominantly vacancies. First, topological point defects have high formation energy, hence they rarely form naturally except in extreme conditions (e.g., rapid quenching from high temperatures or under irradiation).[52,57] However, topological defects in graphene are more likely to appear in the form of line defects such as dislocations and grain boundaries.[81] Second, our proposed microscopic model is based on the physics of vacancy point defects in graphene. Since our model is able to accurately explain the experimental data, we speculate that the vacancy point defects are the dominant factor in shaping the electrode sensitivity.

The AFM studies of the surface morphology showed that our graphene electrodes mostly consist of basal planes with minimal density of step edges. Thus, we suggest that the line defects in our multilayer graphene films are predominantly dislocations and grain boundaries. Additional studies that explore the relationship between specific sub-types of defects and the electrode sensitivity (e.g., using STM) will be useful in further refining the theory of the sensor operation.

Our proposed quantitative paradigm has far-reaching practical implications. By providing guidelines for optimizing the FSCV sensitivity of carbon-based electrochemical sensors to neuromodulators such as dopamine and serotonin, we enable significant improvements in a wide range of applications from a next generation of neural probes to multiplexed lab-on-a-chip sensing platforms. Specifically, our precise nano-engineering methodology can ensure fabrication of sensor arrays with predictable and homogeneous sensitivity (see Figure S22). This represents an important first step towards the implementation of nano-engineered carbon-based electrodes suitable for compact, multi-channel sensor systems required in large-scale applications. Further, our nano-engineered electrodes overcome an existing obstacle for industrial-scale fabrication of reliable sensors with reproducible electrode sensitivity. Current methods for fabrication of carbon-based electrodes are not developed to optimize the density of point defects. Consequently, they are largely dependent on post-manufacturing measurement for calibration of sensors and are prone to producing minimally responsive sensors that have to be discarded. In contrast, our paradigm enables industrial-scale and targeted nano-manufacturing of carbon-based electrodes that have sensitivity levels far beyond their predecessors.

Materials and Methods

Multilayer graphene films:

CVD multilayer graphene samples were obtained from two commercial vendors: Graphene Supermarket and Graphene Platform, Inc. The CVD films were grown on nickel foils, which were then removed chemically during the layer transfer process using the commercial nickel etchant TFG (Transene Company Inc.). The free-standing CVD films were subsequently mounted on p+ silicon substrates capped with 285 nm thermally grown SiO2. The graphitized samples were produced using a custom-made system. Details of the metal-induced graphitization process is given in section S5 of Supporting Information.

Raman measurements:

To quantify the structural defects in multilayer graphene films, Raman measurements were performed using Horiba Xplora μ-Raman system with a 532 nm incident laser. The Raman spectra were fitted using Lorenztian functions, providing the FWHM and area of the G and D peaks. The curve fitting results were then used to extract the density of line and point defects according to the theoretical simulations described in Ref. [35]. Details of the Raman analysis are given in section S4 of Supporting Information.

FSCV measurements:

To examine the electrode sensitivity, FSCV measurements of dopamine and serotonin (Sigma Aldrich) were performed using a triangular voltage waveform with a scan rate of 400 V/s and a repetition frequency of 10 Hz. The FSCV current signal was measured using a low-noise current amplifier (SR570, Stanford Research Systems) and subsequently digitized using a data acquisition card (NI 6353 X series, National Instruments). A MATLAB control interface was used to operate these instruments. For sensing measurements, the biomolecules were dissolved in a 1x phosphate buffer saline (PBS) solution. PBS was prepared using the recipe in Ref. [82].

Supplementary Material

supplementary

Acknowledgements:

This research used resources of the Center for Functional Nanomaterials, which is a U.S. DOE Office of Science Facility, at Brookhaven National Laboratory under Contract No. DE-SC0012704. We also acknowledge the Surface Science Facility of CUNY Advanced Science Research Center for the use of the XPS tool. DS acknowledges partial financial support by NSF-CMMI award 1728051. RK is supported by the National Institute of Mental Health grant R01MH109180, a Pew Scholarship in the Biomedical Sciences, and Simons Collaboration on the Global Brain. The authors acknowledge J. Uichanco for helpful discussions.

The authors acknowledge the following patent applications: U.S. Serial No. 62/599,303 and U.S. Serial No. 62/539,045.

Footnotes

Competing Interests:

References

  • [1].Gao W, Emaminejad S, Nyein HYY, Challa S, Chen K, Peck A, Fahad HM, Ota H, Shiraki H, Kiriya D, Lien D-H, Brooks GA, Davis RW, Javey A, Nature 2016, 529, 509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [2].Xuan X, Hossain MF, Park JY, Sci. Rep 2016, 6, 33125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [3].Nasri B, Wu T, Alharbi A, You K, Gupta M, Sebastian SP, Kiani R, Shahrjerdi D, IEEE Trans. Biomed. Circuits Syst 2017, 11, 1192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [4].Xuan X, Yoon HS, Park JY, Biosens. Bioelectron. 2018, 109, 75. [DOI] [PubMed] [Google Scholar]
  • [5].Shao Y, Wang J, Wu H, Liu J, Aksay IA, Lin Y, Electroanalysis 2010, 22, 1027. [Google Scholar]
  • [6].Jacobs CB, Peairs MJ, Venton BJ, Anal. Chim. Acta 2010, 662, 105. [DOI] [PubMed] [Google Scholar]
  • [7].Zhu Z, Nano-Micro Lett 2017, 9, 25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [8].Sinkala E, McCutcheon JE, Schuck MJ, Schmidt E, Roitman MF, Eddington DT, Lab Chip 2012, 12, 2403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [9].Rice RJ, Pontikos NM, McCreery RL, J. Am. Chem. Soc 1990, 112, 4617. [Google Scholar]
  • [10].McCreery RL, Chem. Rev 2008, 108, 2646. [DOI] [PubMed] [Google Scholar]
  • [11].Banks CE, Davies TJ, Wildgoose GG, Compton RG, Chem. Commun 2005, 829. [DOI] [PubMed] [Google Scholar]
  • [12].Banks CE, Compton RG, Analyst 2006, 131, 15. [DOI] [PubMed] [Google Scholar]
  • [13].Ji X, Banks CE, Xi W, Wilkins SJ, Compton RG, J. Phys. Chem. B 2006, 110, 22306. [DOI] [PubMed] [Google Scholar]
  • [14].Brownson DA, Banks CE, The handbook of graphene electrochemistry, Springer, 2014. [Google Scholar]
  • [15].Schmidt AC, Wang X, Zhu Y, Sombers LA, ACS Nano 2013, 7, 7864. [DOI] [PubMed] [Google Scholar]
  • [16].Keeley GP, McEvoy N, Nolan H, Holzinger M, Cosnier S, Duesberg GS, Chem. Mater. 2014, 26, 1807. [Google Scholar]
  • [17].Gao G, Pan M, Vecitis CD, J. Mater. Chem. A 2015, 3, 7575. [Google Scholar]
  • [18].Chung C, Kim YK, Shin D, Ryoo SR, Hong BH, Min DH, Acc. Chem. Res 2013, 46, 2211. [DOI] [PubMed] [Google Scholar]
  • [19].Lai SCS, Patel AN, McKelvey K, Unwin PR, Angew. Chem 2012, 51, 5405. [DOI] [PubMed] [Google Scholar]
  • [20].Patel AN, Collignon MG, O’Connell MA, Hung WOY, McKelvey K, Macpherson JV, Unwin PR, J. Am. Chem. Soc 2012, 134, 20117. [DOI] [PubMed] [Google Scholar]
  • [21].Patel AN, McKelvey K, Unwin PR, J. Am. Chem. Soc 2012, 134, 20246. [DOI] [PubMed] [Google Scholar]
  • [22].Patel AN, Tan S.-y., Unwin PR, Chem. Commun 2013, 49, 8776. [DOI] [PubMed] [Google Scholar]
  • [23].Zhang G, Cuharuc AS, Güell AG, Unwin PR, Phys. Chem. Chem. Phys 2015, 17, 11827. [DOI] [PubMed] [Google Scholar]
  • [24].Frederix PL, Bosshart PD, Akiyama T, Chami M, Gullo MR, Blackstock JJ, Dooleweerdt K, De Rooij NF, Staufer U, Engel A, Nanotechnology 2008, 19, 384004. [DOI] [PubMed] [Google Scholar]
  • [25].Anne A, Bahri MA, Chovin A, Demaille C, Taofifenua C, Phys. Chem. Chem. Phys 2014, 16, 4642. [DOI] [PubMed] [Google Scholar]
  • [26].Zhong JH, Zhang J, Jin X, Liu JY, Li Q, Li MH, Cai W, Wu DY, Zhan D, Ren B, J. Am. Chem. Soc 2014, 136, 16609. [DOI] [PubMed] [Google Scholar]
  • [27].Güell AG, Cuharuc AS, Kim YR, Zhang G, Tan S. y., Ebejer N, Unwin PR, ACS Nano 2015, 9, 3558. [DOI] [PubMed] [Google Scholar]
  • [28].McCreery R, Bergren A, Morteza-Najarian A, Sayed SY, Yan H, Faraday Discuss 2014, 172, 9. [DOI] [PubMed] [Google Scholar]
  • [29].E SP, Kim YR, Perry D, Bentley CL, Unwin PR, ACS Appl. Mater. Interfaces 2016, 8, 30458. [DOI] [PubMed] [Google Scholar]
  • [30].Jiang L, Fu W, Birdja YY, Koper MTM, Schneider GF, Nat. Commun 2018, 9, 793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [31].Tuinstra F, Koenig JL, J. Chem. Phys 1970, 53, 1126. [Google Scholar]
  • [32].Cançado LG, Takai K, Enoki T, Endo M, Kim YA, Mizusaki H, Jorio A, Coelho LN, Magalhães-Paniago R, Pimenta MA, Appl. Phys. Lett 2006, 88, 163106. [Google Scholar]
  • [33].Lucchese MM, Stavale F, Ferreira EHM, Vilani C, Moutinho MVO, Capaz RB, Achete CA, Jorio A, Carbon 2010, 48, 1592. [Google Scholar]
  • [34].Cançado LG, Jorio A, Ferreira EHM, Stavale F, Achete CA, Capaz RB, Moutinho MVO, Lombardo A, Kulmala TS, Ferrari AC, Nano Lett 2011, 11, 3190. [DOI] [PubMed] [Google Scholar]
  • [35].Cançado LG, Silva MGD, Ferreira EHM, Hof F, Kampioti K, Huang K, Pénicaud A, Achete CA, Capaz RB, Jorio A, 2D Mater. 2017, 4, 025039. [Google Scholar]
  • [36].Wightman RM, May LJ, Michael AC, Anal. Chem 1988, 60, 769A. [DOI] [PubMed] [Google Scholar]
  • [37].Wightman RM, Robinson DL, Neurochem J. 2002, 82, 721. [DOI] [PubMed] [Google Scholar]
  • [38].Kishida KT, Saez I, Lohrenz T, Witcher MR, Laxton AW, Tatter SB, White JP, Ellis TL, Phillips PEM, Montague PR, Proc. Natl. Acad. Sci 2016, 113, 200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [39].Kuhr WG, Wightman RM, Brain Res 1986, 381, 168. [DOI] [PubMed] [Google Scholar]
  • [40].Venton BJ, Wightman RM, Anal. Chem 2003, 75, 414A. [Google Scholar]
  • [41].Reina A, Jia X, Ho J, Nezich D, Son H, Bulovic V, Dresselhaus MS, Kong J, Nano Lett 2009, 9, 30. [DOI] [PubMed] [Google Scholar]
  • [42].Li X, Magnuson CW, Venugopal A, Tromp RM, Hannon JB, Vogel EM, Colombo L, Ruoff RS, J. Am. Chem. Soc 2011, 133, 2816. [DOI] [PubMed] [Google Scholar]
  • [43].Li X, Zhu Y, Cai W, Borysiak M, Han B, Chen D, Piner RD, Colombo L, Ruoff RS, Nano Lett 2009, 9, 4359. [DOI] [PubMed] [Google Scholar]
  • [44].Kim KS, Zhao Y, Jang H, Lee SY, Kim JM, Kim KS, Ahn JH, Kim P, Choi JY, Hong BH, Nature 2009, 457, 706. [DOI] [PubMed] [Google Scholar]
  • [45].Lee Y, Bae S, Jang H, Jang S, Zhu S-E, Sim SH, Song YI, Hong BH, Ahn J-H, Nano Lett 2010, 10, 490. [DOI] [PubMed] [Google Scholar]
  • [46].Bucher ES, Wightman RM, Annu. Rev. Anal. Chem 2015, 8, 239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [47].Glimcher PW, Proc. Natl. Acad. Sci 2011, 108, 15647.21389268 [Google Scholar]
  • [48].Floresco SB, Annu. Rev. Psychol 2015, 66, 25. [DOI] [PubMed] [Google Scholar]
  • [49].Costa RM, Curr. Opin. Neurobiol 2011, 21, 579. [DOI] [PubMed] [Google Scholar]
  • [50].Lee G-D, Wang CZ, Yoon E, Hwang N-M, Kim D-Y, Ho KM, Phys. Rev. Lett 2005, 95, 205501. [DOI] [PubMed] [Google Scholar]
  • [51].Vicarelli L, Heerema SJ, Dekker C, Zandbergen HW, ACS Nano 2015, 9, 3428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [52].Banhart F, Kotakoski J, Krasheninnikov AV, ACS Nano 2011, 5, 26. [DOI] [PubMed] [Google Scholar]
  • [53].Zhang LL, Zhao X, Ji H, Stoller MD, Lai L, Murali S, Mcdonnell S, Cleveger B, Wallace RM, Ruoff RS, Energy Environ. Sci 2012, 5, 9618. [Google Scholar]
  • [54].Ferrari AC, Solid State Commun 2007, 143, 47. [Google Scholar]
  • [55].Ferrari AC, Basko DM, Nat. Nanotechnol 2013, 8, 235. [DOI] [PubMed] [Google Scholar]
  • [56].Beams R, Cançado LG, Novotny L, Nano Lett 2011, 11, 1177. [DOI] [PubMed] [Google Scholar]
  • [57].Kotakoski J, Meyer JC, Kurasch S, Santos-Cottin D, Kaiser U, Krasheninnikov AV, Phys. Rev. B 2011, 83, 245420. [Google Scholar]
  • [58].Li L, Reich S, Robertson J, Phys. Rev. B 2005, 72, 184109. [Google Scholar]
  • [59].Mao J, Jiang Y, Moldovan D, Li G, Watanabe K, Taniguchi T, Masir MR, Peeters FM, Andrei EY, Nat. Phys 2016, 12, 545. [DOI] [PubMed] [Google Scholar]
  • [60].Ruffieux P, Melle-Franco M, Gröning O, Bielmann M, Zerbetto F, Gröning P, Phys. Rev. B 2005, 71, 153403. [Google Scholar]
  • [61].Ugeda MM, Brihuega I, Guinea F, Gómez-Rodríguez JM, Phys. Rev. Lett 2010, 104, 096804. [DOI] [PubMed] [Google Scholar]
  • [62].Massabeau S, Baillergeau M, Phuphachong T, Berger C, de Heer WA, Dhillon S, Tignon J, de Vaulchier LA, Ferreira R, Mangeney J, Phys. Rev. B 2017, 95, 085311. [Google Scholar]
  • [63].Pereira VM, Guinea F, Lopes dos Santos JMB, Peres NMR, Castro Neto AH, Phys. Rev. Lett 2006, 96, 036801. [DOI] [PubMed] [Google Scholar]
  • [64].Pereira VM, Lopes dos Santos JMB, Castro Neto AH, Phys. Rev. B 2008, 77, 115109. [Google Scholar]
  • [65].Valencia AM, Caldas MJ, Phys. Rev. B 2017, 96, 125431. [Google Scholar]
  • [66].Gerischer H, Physical chemistry: an advanced treatise, Vol. 9A, Academic Press, Inc: New York, 1970. [Google Scholar]
  • [67].Marcus RA, Pure Appl. Chem 1997, 69, 13. [Google Scholar]
  • [68].Bard AJ, Faulkner LR, Leddy J, Zoski CG, Electrochemical methods: fundamentals and applications, Vol. 2, Wiley; New York, 1980. [Google Scholar]
  • [69].Sato N, Electrochemistry at metal and semiconductor electrodes, Elsevier Science, 2003. [Google Scholar]
  • [70].Wang K, Tai G, Wong KH, Lau SP, Guo W, AIP Adv. 2011, 1, 022141. [Google Scholar]
  • [71].Hass J, Heer W. A. d., Conrad EH, J. Phys.: Condens. Matter 2008, 20, 323202. [Google Scholar]
  • [72].Cao H, Yu Q, Colby R, Pandey D, Park CS, Lian J, Zemlyanov D, Childres I, Drachev V, Stach EA, Hussain M, Li H, Pei SS, Chen YP, J. Appl. Phys 2010, 107, 044310. [Google Scholar]
  • [73].Rodríguez-Manzo JA, Pham-Huu C, Banhart F, ACS Nano 2011, 5, 1529. [DOI] [PubMed] [Google Scholar]
  • [74].Berman D, Deshmukh SA, Narayanan B, Sankaranarayanan SKRS, Yan Z, Balandin AA, Zinovev A, Rosenmann D, Sumant AV, Nat. Commun 2016, 7, 12099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [75].Schluter EW, Mitz AR, Cheer JF, Averbeck BB, PLoS One 2014, 9, e98692. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [76].Zachek MK, Takmakov P, Moody B, Wightman RM, McCarty GS, Anal. Chem 2009, 81, 6258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [77].Robinson DL, Venton BJ, Heien MLAV, Wightman RM, Clin. Chem 2003, 49, 1763. [DOI] [PubMed] [Google Scholar]
  • [78].Cline KK, McDermott MT, McCreery RL, J. Phys. Chem 1994, 98, 5314. [Google Scholar]
  • [79].Winterer G, Weinberger DR, Trends NeuroSci 2004, 27, 683. [DOI] [PubMed] [Google Scholar]
  • [80].McCreery RL, McDermott MT, Anal. Chem 2012, 84, 2602. [DOI] [PubMed] [Google Scholar]
  • [81].Yazyev OV, Louie SG, Phys. Rev. B 2010, 81, 195420. [DOI] [PubMed] [Google Scholar]
  • [82].Chazotte B, Cold Spring Harb. Protoc 2012, 913. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

supplementary

RESOURCES